000 01408 a2200385 4500
005 20250515011832.0
264 0 _c20060331
008 200603s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.50.1.399-400.2006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeleg, Anton Y
245 0 0 _aOXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJan 2006
300 _a399-400 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAcinetobacter
_xdrug effects
650 0 4 _aAcinetobacter Infections
_xblood
650 0 4 _aAustralia
650 0 4 _aCarbapenems
_xmetabolism
650 0 4 _aDNA, Bacterial
_xanalysis
650 0 4 _aDrug Resistance, Bacterial
_xphysiology
650 0 4 _aHumans
650 0 4 _aHydrolysis
650 0 4 _aImidazoles
_xantagonists & inhibitors
650 0 4 _aPiperidines
_xantagonists & inhibitors
650 0 4 _abeta-Lactamase Inhibitors
650 0 4 _abeta-Lactamases
_xmetabolism
700 1 _aFranklin, Clare
700 1 _aWalters, Luke J
700 1 _aBell, Jan M
700 1 _aSpelman, Denis W
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 50
_gno. 1
_gp. 399-400
856 4 0 _uhttps://doi.org/10.1128/AAC.50.1.399-400.2006
_zAvailable from publisher's website
999 _c15996247
_d15996247